Cargando…

The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases

PURPOSE: As an alternative to technetium-99m-macroaggregated albumin ((99m)Tc-MAA), a scout dose of holmium-166 ((166)Ho) microspheres can be used prior to (166)Ho-radioembolization. The use of identical particles for pre-treatment and treatment procedures may improve the predictive value of pre-tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Smits, Maarten L. J., Dassen, Mathijs G., Prince, Jip F., Braat, Arthur J. A. T., Beijst, Casper, Bruijnen, Rutger C. G., de Jong, Hugo W. A. M., Lam, Marnix G. E. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075844/
https://www.ncbi.nlm.nih.gov/pubmed/31399801
http://dx.doi.org/10.1007/s00259-019-04460-y
Descripción
Sumario:PURPOSE: As an alternative to technetium-99m-macroaggregated albumin ((99m)Tc-MAA), a scout dose of holmium-166 ((166)Ho) microspheres can be used prior to (166)Ho-radioembolization. The use of identical particles for pre-treatment and treatment procedures may improve the predictive value of pre-treatment analysis of distribution. The aim of this study was to analyze the agreement between (166)Ho-scout and (166)Ho-therapeutic dose in comparison with the agreement between (99m)Tc-MAA and (166)Ho-therapeutic dose. METHODS: Two separate scout dose procedures were performed ((99m)Tc-MAA and (166)Ho-scout) before treatment in 53 patients. First, qualitative assessment was performed by two blinded nuclear medicine physicians who visually rated the agreement between the (99m)Tc-MAA, (166)Ho-scout, and (166)Ho-therapeutic dose SPECT-scans (i.e., all performed in the same patient) on a 5-point scale. Second, agreement was measured quantitatively by delineating lesions and normal liver on FDG-PET/CT. These volumes of interest (VOIs) were co-registered to the SPECT/CT images. The predicted absorbed doses (based on (99m)Tc-MAA and (166)Ho-scout) were compared with the actual absorbed dose on post-treatment SPECT. RESULTS: A total of 23 procedures (71 lesions, 22 patients) were included for analysis. In the qualitative analysis, (166)Ho-scout was superior with a median score of 4 vs. 2.5 for (99m)Tc-MAA (p < 0.001). The quantitative analysis showed significantly narrower 95%-limits of agreement for (166)Ho-scout in comparison with (99m)Tc-MAA when evaluating lesion absorbed dose (− 90.3 and 105.3 Gy vs. − 164.1 and 197.0 Gy, respectively). Evaluation of normal liver absorbed dose did not show difference in agreement between both scout doses and (166)Ho-therapeutic dose (− 2.9 and 5.5 Gy vs − 3.6 and 4.1 Gy for (99m)Tc-MAA and (166)Ho-scout, respectively). CONCLUSIONS: In this study, (166)Ho-scout was shown to have a superior predictive value for intrahepatic distribution in comparison with (99m)Tc-MAA.